Clinical Trials Browser

Phase 2 × Uterine Cervical Neoplasms × Neoadjuvant Therapy × Clear all

NCT06878222 2025-04-01

Iparomlimab and Tuvonralimab Combined With Paclitaxel and Cisplatin as Neoadjuvant Therapy for CC

Phase 2 Recruiting

Uterine Cervical Neoplasms

NCT00462397 2013-08-26

Paclitaxel and Carboplatin Followed by Cisplatin and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer

Phase 2 Unknown

Uterine Cervical Neoplasms